Metrics to compare | 002864 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship002864PeersSector | |
|---|---|---|---|---|
P/E Ratio | 35.0x | 29.8x | −0.4x | |
PEG Ratio | −1.26 | 0.92 | 0.00 | |
Price/Book | 1.8x | 2.5x | 2.6x | |
Price / LTM Sales | 2.7x | 3.6x | 3.1x | |
Upside (Analyst Target) | - | 33.1% | 48.5% | |
Fair Value Upside | Unlock | 13.9% | 5.8% | Unlock |
Shaanxi Panlong Pharmaceutical Group Co., Ltd. researches and develops, produces, and sells Chinese patent medicines and traditional Chinese medicine formula granules in China. The company offers orthopedic, cardiovascular, cerebrovascular, digestive, respiratory, pediatrics, gynecology, hepatobiliary, rheumatism and bone injury, tonic, heat-clearing and detoxifying, and liver and gallbladder drugs, as well as supplements and traditional Chinese medicine anti-inflammatory products. It also offers health food, health products, functional health food, and daily chemical products. The company was formerly known as Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd and changed its name to Shaanxi Panlong Pharmaceutical Group Co., Ltd. in May 2026. Shaanxi Panlong Pharmaceutical Group Co., Ltd. was founded in 1997 and is headquartered in Xi'an, China.